Aligos Therapeutics's total assets for Q4 2025 were $89.58M, a decrease of -18.39% from the previous quarter. ALGS total liabilities were $36.04M for the fiscal quarter, a -4.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.